Revenue
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Angiodynamics Inc (ANGO)
Price$15.20Cached quote
Net income
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Free cash flow
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total cash / debt
CashTotal debt
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Financial statements
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $320.2M | $292.5M | $303.9M | $338.8M | $316.2M | $291.0M | $264.2M | $270.6M | $261.7M | $269.8M | $353.9M | $356.5M | $354.4M | $341.9M | $221.9M | $215.6M | $216.0M |
| Gross profit | $174.9M | $157.7M | $154.7M | $174.2M | $165.7M | $156.8M | $150.3M | $156.0M | $143.9M | $143.9M | $174.3M | $175.8M | $180.2M | $168.5M | $125.3M | $125.6M | $127.0M |
| Gross margin | 54.62% | 53.92% | 50.90% | 51.44% | 52.41% | 53.88% | 56.89% | 57.64% | 54.98% | 53.36% | 49.26% | 49.31% | 50.84% | 49.29% | 56.47% | 58.24% | 58.77% |
| Research & development | $29.4M | $26.2M | $31.5M | $29.9M | $30.7M | $36.4M | $29.7M | $28.3M | $24.3M | $24.1M | $25.1M | $26.6M | $28.1M | $26.1M | $20.5M | $21.4M | $19.3M |
| Operating expenses | $214.8M | $197.7M | $401.6M | $225.4M | $194.2M | $192.1M | $317.4M | $165.4M | $158.0M | $155.1M | $173.3M | $179.2M | $169.7M | $163.3M | $130.6M | $113.7M | $106.1M |
| Operating income | −$39.9M | −$40.0M | −$192.4M | −$51.2M | −$28.5M | −$35.3M | −$167.1M | −$9.4M | −$14.2M | −$11.2M | $1.0M | −$3.4M | $10.5M | $5.2M | −$5.2M | $11.9M | $20.9M |
| Operating margin | −12.47% | −13.66% | −63.32% | −15.11% | −9.00% | −12.12% | −63.26% | −3.47% | −5.42% | −4.14% | 0.29% | −0.97% | 2.96% | 1.53% | −2.36% | 5.52% | 9.66% |
| EBITDA | −$17.0M | −$14.2M | −$164.7M | −$20.3M | $878,000 | −$9.4M | −$143.3M | $16.5M | $9.0M | $13.6M | $29.1M | $26.4M | $38.8M | $32.5M | $9.4M | $24.5M | $33.3M |
| EBITDA margin | −5.30% | −4.84% | −54.20% | −5.99% | 0.28% | −3.22% | −54.25% | 6.09% | 3.44% | 5.05% | 8.23% | 7.41% | 10.95% | 9.50% | 4.25% | 11.35% | 15.43% |
| Net income | −$36.7M | −$34.0M | −$184.3M | −$52.4M | −$26.5M | −$31.5M | −$166.8M | $61.3M | $16.3M | $5.0M | −$43.6M | −$3.4M | $2.3M | −$1.1M | −$5.3M | $8.1M | $12.3M |
| Net profit margin | −11.48% | −11.62% | −60.66% | −15.48% | −8.40% | −10.84% | −63.14% | 22.67% | 6.24% | 1.86% | −12.32% | −0.95% | 0.66% | −0.31% | −2.40% | 3.75% | 5.70% |
| Basic EPSper basic share | -$0.88 | -$0.83 | -$4.59 | -$1.33 | -$0.68 | -$0.82 | -$4.39 | $1.64 | $0.44 | $0.14 | -$1.21 | -$0.09 | $0.07 | -$0.03 | -$0.20 | $0.33 | $0.50 |
| Diluted EPSper diluted share | -$0.88 | -$0.83 | -$4.59 | -$1.33 | -$0.68 | -$0.82 | -$4.39 | $1.64 | $0.44 | $0.14 | -$1.21 | -$0.09 | $0.07 | -$0.03 | -$0.20 | $0.32 | $0.50 |
Owners
Reported shareholders
≈9.12%of listed shares
BlackRock, Inc.3.8M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
BlackRock, Inc. | ≈9.12%3.8M shares |
Point72 Asset Management, L.P. | ≈7.34%3.06M shares |
SYSTEMATIC FINANCIAL MANAGEMENT LP | ≈6.33%2.64M shares |
ARMISTICE CAPITAL, LLC | ≈5.27%2.2M shares |
ROYCE & ASSOCIATES LP | ≈4.72%1.97M shares |
Broadfin Holdings LLC | ≈4.36%1.82M shares |
VANGUARD CAPITAL MANAGEMENT LLC | ≈4.06%1.69M shares |
WEBER CAPITAL MANAGEMENT LLC /ADV | ≈3.25%1.36M shares |
Nuveen, LLC | ≈2.88%1.2M shares |
GEODE CAPITAL MANAGEMENT, LLC | ≈2.45%1.02M shares |
DIMENSIONAL FUND ADVISORS LP | ≈2.32%969.5K shares |
STATE STREET CORP | ≈2.30%958.17K shares |
SEGALL BRYANT & HAMILL, LLC | ≈2.22%926.71K shares |
Bastion Asset Management Inc. | ≈2.21%923.27K shares |
Clemmer James C | ≈2.12%882.53K shares |
Pier Capital, LLC | ≈1.93%806.68K shares |
MILLENNIUM MANAGEMENT LLC | ≈1.88%783.13K shares |
RENAISSANCE TECHNOLOGIES LLC | ≈1.76%733.88K shares |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | ≈1.66%692.53K shares |
PARADIGM CAPITAL MANAGEMENT INC/NY | ≈1.61%671.2K shares |
Percentages use 41.7M shares of this listed class outstanding on May 31, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Oct 21, 2025Form 4 | Weiss Lawrence TSVP, Chief Legal Officer | BuyCommon Stock | 10.0K | $11.81 | $118.1K | 93.6K |
| Oct 13, 2025Form 4 | Trowbridge Stephen AEVP and CFO | BuyCommon Stock | 890 | $11.16 | $9.9K | 256.6K |
| Oct 9, 2025Form 4 | Clemmer James CPresident and CEO | BuyCommon Stock | 10.0K | $11.15 | $111.5K | 882.5K |
| Jan 16, 2025Form 4 | Nighan Warren JRSVP Quality and Regulatory | SellCommon Stock | 4.1K | $12.31 | $50.0K | 41.8K |
| Oct 10, 2024Form 4 | Nighan Warren JRSVP Quality and Regulatory | BuyCommon Stock | 100 | $6.08 | $608.00 | 45.9K |